Page 151 - THE EVOLUTION OF EARLY ARTHRITIS AND CARDIOVASCULAR RISK Samina A. Turk

27. Norton S, Fu B, Scott DL, Deighton C, Symmons DP, Wailoo AJ, et al. Health Assessment Questionnaire disability progression in early rheumatoid arthritis: systematic review and analysis of two inception cohorts. Semin Arthritis Rheum 2014;44:131-44.
28. BaloghE,MadrugaDJ,OrrC,MullanR,HartyL,FitzGeraldO,etal.Comparisonofremission criteria in a tumour necrosis factor inhibitor treated rheumatoid arthritis longitudinal cohort: patient global health is a confounder. Arthritis Res Ther 2013;15:R221.
29. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
30. LedinghamJM,SnowdenN,RivettA,GallowayJ,IdeZ,FirthJ,etal.Patient-andclinician- reported outcomes for patients with new presentation of inflammatory arthritis: observations from the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis. Rheumatology (Oxford) 2017;56:231-8.
31. Ter Wee MM, den UD, Boers M, Kerstens P, Nurmohamed M, van SD, et al. Intensive combination treatment regimens, including prednisolone, are effective in treating patients with early rheumatoid arthritis regardless of additional etanercept: 1-year results of the COBRA-light open-label, randomised, non-inferiority trial. Ann Rheum Dis 2015;74:1233-40.
32. GulfeA,GeborekP,SaxneT.Responsecriteriaforrheumatoidarthritisinclinicalpractice: how useful are they? Ann Rheum Dis 2005;64:1186-9.
33. KoikeT,KazumaK,KawamuraS.Therelationshipbetweenfatigue,copingbehavior,and inflammation in patients with rheumatoid arthritis. Mod Rheumatol 2000;10:141-9.
34. Rohleder N, Aringer M, Boentert M. Role of interleukin-6 in stress, sleep, and fatigue.
Ann N Y Acad Sci 2012;1261:88-96.
PAIN, SLEEP AND EMOTIONAL WELL-BEING
149
7